| FOLFIRI Regimen studied in …STUDIED_INderived136 of 136show fewer |
|---|
| → studied in | NCT07446322Phase 2 · recruiting FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer · 136 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793958Phase 3 · active not recruiting Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06663319Phase 1 · recruiting A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers · 136 trials list this drug (29 active) | — | — | Digestive System Neoplasm,Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07221357Phase 2/Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445062Phase 1/Phase 2 · recruiting Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors · 136 trials list this drug (29 active) | — | — | Malignant Digestive System Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05786924Phase 1/Phase 2 · recruiting Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies · 136 trials list this drug (29 active) | — | — | Solid Neoplasm,Histiocytic and Dendritic Cell Neoplasm,Malignant Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04485013Phase 1 · active not recruiting TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929223Phase 1 · recruiting A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702032Phase 3 · recruiting Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) · 136 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252649Phase 3 · recruiting Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07790510Phase 1/Phase 2 · recruiting HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00265850Phase 3 · completed Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836324Phase 1 · recruiting A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors · 136 trials list this drug (29 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06179160Phase 1 · recruiting A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation · 136 trials list this drug (29 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879055Phase 2 · active not recruiting A Study of PM8002 in Combination With Chemotherapy in Patients With NEN · 136 trials list this drug (29 active) | — | — | Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03081143Phase 2/Phase 3 · completed Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy · 136 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06106308Phase 2 · active not recruiting Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation · 136 trials list this drug (29 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649655Phase 1 · not yet recruiting EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07011576Phase 2 · recruiting A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318389early Phase 1 · not yet recruiting ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419479Phase 1/Phase 2 · suspended Switch Maintenance in Pancreatic · 136 trials list this drug (29 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Neoplasm,Pancreatic Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00959647Phase 2 · completed A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study · 136 trials list this drug (29 active) | — | — | Basal Cell Carcinoma,Malignant Ovarian Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05004350Phase 2 · completed A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer. · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03798626Phase 1 · completed Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983367Phase 2 · terminated A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07323576Phase 2 · withdrawn A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391566Phase 1/Phase 2 · not yet recruiting LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00208260Phase 2/Phase 3 · completed Intensified Chemotherapy in CRC After Resection of Liver Metastases · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389265Phase 3 · recruiting Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07337447Phase 2 · not yet recruiting Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01) · 136 trials list this drug (29 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05008809Phase 3 · recruiting Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06747845Phase 2 · recruiting Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy · 136 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02820857Phase 2 · completed Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer · 136 trials list this drug (29 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06867822Phase 1 · recruiting Trial of ProAgio in Advanced/Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05480306Phase 2 · completed Phase 2 Study of DKN-01 in Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03806309Phase 2 · active not recruiting OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021950Phase 2 · not yet recruiting AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05312398Phase 2 · active not recruiting CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen · 136 trials list this drug (29 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03597581Phase 1 · completed A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Digestive System Neoplasm,Gastric Neoplasm,Malignant Digestive System Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04553692Phase 1 · terminated Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers · 136 trials list this drug (29 active) | — | — | Solid Neoplasm,Sarcoma,Chondrosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04952753Phase 2 · terminated Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256707Phase 1/Phase 2 · completed Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03829410Phase 1/Phase 2 · completed Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05087992Phase 1 · completed A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers · 136 trials list this drug (29 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117972Phase 2 · terminated Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05593328Phase 2 · completed Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167725Phase 3 · terminated Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635021Phase 3 · active not recruiting Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02563002Phase 3 · completed Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) · 136 trials list this drug (29 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04926545NA · completed XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study) · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02352337Phase 2 · completed First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem · 136 trials list this drug (29 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02827201Phase 2 · completed FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine · 136 trials list this drug (29 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03250832Phase 1 · completed Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors · 136 trials list this drug (29 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04446793no longer available Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946074Phase 1 · completed A Study of ABT-165 in Subjects With Solid Tumors · 136 trials list this drug (29 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01133990Phase 1/Phase 2 · terminated FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04259944Phase 2 · unknown Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial · 136 trials list this drug (29 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01347645Phase 1/Phase 2 · terminated Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02023593Phase 2 · completed FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma · 136 trials list this drug (29 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05684211Phase 2 · unknown A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03082209Phase 1 · completed A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies · 136 trials list this drug (29 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05634590Phase 2 · unknown The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326000Phase 2 · completed A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339183Phase 3 · completed Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936832Phase 2 · withdrawn Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362617Phase 3 · unknown mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03454620Phase 1/Phase 2 · completed A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy · 136 trials list this drug (29 active) | — | — | Solid Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05193292Phase 2 · unknown Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Intestinal Neoplasm,Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01276379Phase 2 · completed Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04270929Phase 1 · withdrawn Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma · 136 trials list this drug (29 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942706Phase 2/Phase 3 · unknown Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066274Phase 2 · completed Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005979Phase 3 · completed Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298570Phase 2 · completed Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023868Phase 3 · terminated Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03692429Phase 1 · recruiting alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02482441Phase 1 · completed A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 · 136 trials list this drug (29 active) | — | — | Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035253Phase 1 · terminated A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02484833Phase 3 · completed Erbitux MEtastatic Colorectal Cancer Strategy Study · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00952029Phase 2/Phase 3 · completed Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00508404Phase 2 · completed Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568046Phase 1/Phase 2 · terminated Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605044Phase 3 · terminated Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02305758Phase 2 · completed Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551213Phase 2 · completed A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506167completed An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01571284Phase 3 · completed Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen · 136 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01888978Phase 2 · completed Molecularly Tailored Therapy for Pancreas Cancer · 136 trials list this drug (29 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01472016Phase 1 · completed Study of ABT-700 in Subjects With Advanced Solid Tumors · 136 trials list this drug (29 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01704703Phase 2 · completed Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00636610Phase 2 · completed A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00497497Phase 1 · completed A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00154102Phase 3 · completed Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL) · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978313Phase 2/Phase 3 · unknown Cetuximab Monotherapy Maintenance Treatment in mCRC · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00671372Phase 1 · completed A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01085331Phase 1/Phase 2 · terminated MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454116Phase 2 · completed A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02033551Phase 1 · completed A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors · 136 trials list this drug (29 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01937715Phase 1/Phase 2 · terminated A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00332163Phase 2 · completed Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00411450Phase 2 · completed Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm,Malignant Colon Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01434069Phase 1 · completed Phase I Trial of Combination of FOLFIRI and SOM 230 · 136 trials list this drug (29 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00752570Phase 2 · completed A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm,Carcinoma,Malignant Digestive System Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00440310Phase 3 · completed Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00778830Phase 1/Phase 2 · completed Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study) · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020488Phase 1 · completed Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors · 136 trials list this drug (29 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01277406Phase 1/Phase 2 · completed 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma · 136 trials list this drug (29 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01219920Phase 3 · completed FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01205711Phase 2 · completed Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01068132Phase 2 · completed Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01605344Phase 1 · withdrawn Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI · 136 trials list this drug (29 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027833Phase 2 · unknown Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005607Phase 2 · unknown Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus · 136 trials list this drug (29 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008060Phase 3 · completed Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021281Phase 3 · unknown Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01124630Phase 1 · completed Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719199Phase 1 · terminated Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00615056Phase 2 · completed A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01736904Phase 2 · unknown wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00561470Phase 3 · completed Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004885Phase 3 · completed Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064181Phase 3 · completed Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101894Phase 1 · completed Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026273Phase 3 · completed Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00286130Phase 2 · completed Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020501Phase 3 · completed Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver · 136 trials list this drug (29 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01543412Phase 2 · completed Second Line Chemotherapy for Advanced Pancreatic Cancer · 136 trials list this drug (29 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313872Phase 3 · completed Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer · 136 trials list this drug (29 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00786006Phase 2 · completed Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer · 136 trials list this drug (29 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00668863Phase 2 · completed Study Of Sunitinib With FOLFIRI In Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00374036Phase 3 · completed Metastatic Gastric Cancer FFCD 03-07 · 136 trials list this drug (29 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00839111Phase 2 · unknown Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment · 136 trials list this drug (29 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091312Phase 3 · unknown Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003260Phase 3 · unknown Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006115Phase 2 · unknown Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075595Phase 2 · unknown Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer · 136 trials list this drug (29 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |